Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Limb injury
Clinical narrative: the band-aide on his R arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 77-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 13Oct2023 as dose 1, single (Batch/Lot number: unknown) at the age of 76 years for covid-19 immunisation. The patient's relevant medical history included: "stroke", start date: 04Jun2021 (unspecified if ongoing), notes: high doses of prednisone after diagnosis; "Penicillin allergy" (unspecified if ongoing); "Type 2 Diabetes/Diabetes mellitus" (ongoing), notes: Not sure may be 16 years; "Aortic Stenosis", start date: 2015 (unspecified if ongoing), notes: Valve replaced Sep2015; "Varicella Encephalitis", start date: Jun2021 (ongoing), notes: increase Ig6 to varicella vasculitis; "Pulmonary embolism", start date: 12Aug2021 (ongoing); "Hypothyroid" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "Hyperlipidemia" (unspecified if ongoing); "VZV encephalitis", start date: 04Jan2021 (ongoing), notes: high doses of prednisone after diagnosis; "Valve replaced", start date: Sep2015 (not ongoing). Concomitant medication(s) included: FLUZONE HIGH DOSE QUADRIVALENT taken for influenza immunisation, on 05Oct2021 as dose 1, single; JANUVIA oral taken for type 2 diabetes mellitus; LEVOTHYROXINE oral taken for hypothyroidism (ongoing); FUROSEMIDE oral taken for hypertension; LIPTOR [ATORVASTATIN CALCIUM] oral taken for hyperlipidaemia; ASPIRIN [ACETYLSALICYLIC ACID] taken for prophylaxis; OMEPRAZOLE; FAMOTIDINE; LASIX [FUROSEMIDE] (ongoing); MELATONIN. Past drug history included: Metformin, reaction(s): "Allergy". Vaccination history included: bnt162b2 (DOSE 1, SINGLE, Batch/lot: EK9231, Anatomical Location: right arm , Route: Intramuscular), administration date: 16Jan2021, for COVID-19 immunisation; bnt162b2 (DOSE 2, SINGLE, Batch/lot: EL9265, Anatomical Location: right arm , Route: Intramuscular), administration date: 06Feb2021, for COVID-19 immunisation, reaction(s): "stroke/ 3 strokes", "Pulmonary embolism", "cognitive issues", "develop pulmonary blood clots", "encephalitis", "blood clots legs", "strokes were the result of VZV (shingles)", "Vasculitis encephalitis/ Varicella zoaster", "strokes were the result of VZV (shingles)", "Varicella Encephalitis"; tdap (DOSE 1, SINGLE), administration date: 27Sep2007, for Immunisation; tdap (DOSE 2, SINGLE), administration date: 20Feb2020, for Immunisation; pneumovax (DOSE 1, SINGLE, Vaccine: PPSV23 (Pneumovax)), administration date: 05Sep2006, for Immunisation; pneumovax (DOSE 2, SINGLE, Vaccine: PPSV23 (Pneumovax)), administration date: 05May2017, for Immunisation; prevnar (DOSE 1, SINGLE, Vaccine: PCV-13 (Prevnar)), administration date: 14Aug2015, for Immunisation; influenza (DOSE 1, SINGLE, Vaccine: Influenza, Seasonal), administration date: 05Sep2006, for Influenza immunisation; influenza (DOSE 2, SINGLE, Vaccine: Influenza, P-Free), administration date: 26Sep2014, for Influenza immunisation; influenza (DOSE 3, SINGLE, Vaccine: Influenza, P-Free), administration date: 06Oct2015, for Influenza immunisation; influenza (DOSE 4, SINGLE, Vaccine: Influenza, High dose), administration date: 27Sep2006, for Influenza immunisation; influenza (DOSE 5, SINGLE, Vaccine: Influenza, High dose), administration date: 14Sep2017, for Influenza immunisation; influenza (DOSE 6, SINGLE, Vaccine: Influenza, High dose), administration date: 17Sep2018, for Influenza immunisation; influenza quad inj pf (DOSE 7, SINGLE, Vaccine: Influenza Quad Inj PF), administration date: 01Oct2019, for Influenza immunisation; influenza quad inj pf (DOSE 8, SINGLE, Vaccine: Influenza, High-dose Quad), administration date: 01Sep2020, for Influenza immunisation; h1n1 flu 09 (DOSE 1, SINGLE, Vaccine: H1N1 Flu 09), administration date: 14Dec2009, for Influenza immunisation; zostavax (Dose: 1, SINGLE, Vaccine: Zoaster (Zostavax)), administration date: 27Sep2007, for Immunisation; zostavax (Dose: 1, SINGLE, Vaccine: Zoaster (Zostavax)), administration date: 01Apr2012, for Immunisation; bnt162b2 (At 15:15, DOSE 3 (BOOSTER), SINGLE, Batch/Lot number: FE3592, Anatomical location: Arm right), administration date: 11Sep2021, for COVID-19 Immunisation, reaction(s): "Stroke", "strokes were the result of VZV (shingles) activation", "cognitive issues", "blood clots legs". The following information was reported: LIMB INJURY (non-serious) with onset Oct2023, outcome "unknown", described as "the band-aide on his R arm".  Additional information: Patient had been more-or-less bedridden since his first stroke on 04Jun2021 and approximately 6 months after a Covid vaccine.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300331526 Same drug/ different patient/event;US-PFIZER INC-202101850201 same patient/product, different dose/event;US-PFIZER INC-202101850694 same patient/product, different dose (dose 2)/event;